News: Elite Pharmaco joint venture partners in Malta, MGC Pharma
Elite Pharmaco joint venture partners in Malta, MGC Pharma today announced inking a stunning $24 million North American distribution deal with AMC Holdings.
MGC Pharma (‘MGC’) (LSE: MXC) became the first cannabis company to list on the London Stock Exchange in February of this year. MGC Pharmaceuticals are focused on advancing clinical trials and distribution of cannabinoid based therapies. Strategic distribution partnerships are key to MGC mission to expanding the access to such medicines.
Founded by US Healthcare and Ex Government regulatory executives. AMC Holdings is a vehicle to import and distribute specialist phytomedicines into key North American Markets.